Erwin Chun Si from North Port, FL, age 71

Name / Title

Company / Classification

Phones & Addresses

Erwin C Si
Managing

AEGIS FOREVER, LLC

229 S Ortman Dr, Orlando, FL 32811
4430 Prince Hall Blvd, Orlando, FL 32811
146 Gainsborough Ct, Alameda, CA 94502

Erwin Si
Senior Director Preclinical Research

INSITE VISION INCORPORATED
Mfg of Pharmaceutical Preparations · Pharmaceutical Preparations · Pharmaceutical Preparation Manufacturing · Research and Development in the Physical, Engineering, and L

965 Atlantic Ave, Alameda, CA 94501
965 Atlantic Ave, San Francisco, CA 94109
5108658800, 5108655700

Us Patents

Methods And Compositions For Treating And Inhibiting Retinal Neovascularization
view source
US Patent:

7141607, Nov 28, 2006
Filed:

Mar 10, 2000
Appl. No.:

09/523102
Inventors:

Erwin Si - Alameda CA, US
Lyle M. Bowman - Pleasanton CA, US
Assignee:

Insite Vision Incorporated - Alameda CA
International Classification:

A61K 31/215
A61K 31/74
US Classification:

514530, 424 7804
Abstract:

Methods and compositions for the prophylactic and therapeutic treatment of retinal disorders associated with neovascularization using topical ophthalmic compositions comprising hydroxamic acid matrix metalloproteinase inhibitors such as batimastat.

Optineurin Nucleic Acid Molecules And Uses Thereof
view source
US Patent:

20030190617, Oct 9, 2003
Filed:

Mar 6, 2002
Appl. No.:

10/091281
Inventors:

Vincent Raymond - Sainte-Foy, CA
Jean Morissette - Sainte-Foy, CA
Erwin Si - Alameda CA, US
Assignee:

Erwin Si, Vincent Raymond and Jean Morissette
International Classification:

C12Q001/68
C12N005/08
C07H021/04
C12N001/21
US Classification:

435/006000, 435/325000, 435/368000, 435/252300, 536/023200
Abstract:

Promoter sequences of the optineurin gene can be used to diagnose, prognose, and treat glaucoma and related disorders. Methods, kits, and nucleic acids capable of detecting or containing polymorphisms located within the promoter region of the optineurin gene are also provided. The promoter sequences can also be used to generate cells, vectors, and nucleic acids useful in a variety of diagnostic and prognostic methods and kits as well as therapeutic compounds, compositions and methods.

Topical Otic Compositions And Methods Of Topical Treatment Of Prevention Of Otic Infections
view source
US Patent:

20060046970, Mar 2, 2006
Filed:

Aug 31, 2004
Appl. No.:

10/929546
Inventors:

Lyle Bowman - Pleasanton CA, US
Santosh Chandrasekaran - Moraga CA, US
Erwin Si - Alameda CA, US
International Classification:

A61K 31/7048
A61K 31/195
A61K 31/192
US Classification:

514028000, 514569000, 514570000, 514567000, 514171000
Abstract:

A topical otic composition containing an azalide antibiotic. A topical otic composition containing an azalide antibiotic and an medicament. A topical otic composition containing an azalide antibiotic and a polymer suspending agent. And methods for treating or preventing infections in the ear using azalide antibiotic compositions.

Non-Steroidal Anti-Inflammatory Ophthalmic Compositions
view source
US Patent:

20100227928, Sep 9, 2010
Filed:

Mar 5, 2009
Appl. No.:

12/398657
Inventors:

Kamran HOSSEINI - Los Altos CA, US
Lyle M. BOWMAN - Pleasanton CA, US
Erwin C. SI - Alameda CA, US
Stephen Pham - Sacramento CA, US
International Classification:

A61K 31/192
A61P 27/02
US Classification:

514576
Abstract:

The disclosure provides compositions and systems for topical ophthalmic application, which include an aqueous mixture of bromfenac and flowable mucoadhesive polymer, for treating inflammation and inflammatory conditions of the eye.

Stabilization Of Aminosteroids For Topical Ophthalmic And Other Applications
view source
US Patent:

53325826, Jul 26, 1994
Filed:

Dec 2, 1992
Appl. No.:

7/984445
Inventors:

John C. Babcock - Olga WA
Jon R. Polansky - Mill Valley CA
Lyle M. Bowman - Pleasanton CA
Erwin C. Si - Alameda CA
Santosh K. Chandrasekaran - Moraga CA
Assignee:

Insite Vision Incorporated - Alameda CA
International Classification:

A61K 4728
A61K 3159
A61K 3722
A61K 3752
US Classification:

424 7804
Abstract:

The invention provides methods for stabilizing amino-substituted steroid therapeutic agents in topical ophthalmic and other pharmaceutical formulations using effective stabilizing amounts of lightly cross-linked carboxy-containing polymers; Stabilized and stabilized/solubilized pharmaceutical compositions adapted for various routes of administration are also described.

Aminosteroids For Ophthalmic Use
view source
US Patent:

52099261, May 11, 1993
Filed:

Aug 24, 1992
Appl. No.:

7/933574
Inventors:

John C. Babcock - Olga WA
Jon R. Polansky - Mill Valley CA
Lyle M. Bowman - Pleasanton CA
Erwin C. Si - Alameda CA
Santosh K. Chandrasekaran - Moraga CA
Assignee:

InSite Vision Incorporated - Alameda CA
International Classification:

A61K 4728
A61K 3158
A61K 3752
US Classification:

424 7804
Abstract:

Methods and compositions for preventing or treating ophthalmic diseases or disorders wherein an ophthalmically effective amount of the C. sub. 20 through C. sub. 26 aminosteroids of formula XI and their pharmaceutical, acceptable salts, hydrates or solvates is administered in an inert vehicle to arrest oxidation processes damaging to the eye.

Aminosteroids For Ophthalmic Use
view source
US Patent:

52564088, Oct 26, 1993
Filed:

Feb 19, 1992
Appl. No.:

7/836888
Inventors:

John G. Babcock - Olga WA
Jon R. Polansky - Mill Valley CA
Lyle M. Bowman - Pleasanton CA
Erwin C. Si - Alameda CA
Santosh K. Chandrasekaran - Moraga CA
Assignee:

Insite Vision Incorporated - Alameda CA
International Classification:

A61K 4728
A61K 3158
A61K 3752
US Classification:

424 7804
Abstract:

Methods and compositions for preventing or treating ophthalmic diseases or disorders wherein an ophthalmically effective amount of the C. sub. 20 through C. sub. 26 aminosteroids of formula XI and their pharmaceutical, acceptable salts, hydrates or solvates is administered in an inert vehicle to arrest oxidation processes damaging to the eye.

Aminosteroids For Ophthalmic Use
view source
US Patent:

51241544, Jun 23, 1992
Filed:

Jun 12, 1990
Appl. No.:

7/537062
Inventors:

John C. Babcock - Olga WA
Jon R. Polansky - Mill Valley CA
Lyle M. Bowman - Pleasanton CA
Erwin C. Si - Alameda CA
Santosh K. Chandrasekran - Moraga CA
Assignee:

InSite Vision Incorporated - Alameda CA
International Classification:

A61K 4728
A61K 3158
A61K 3722
US Classification:

424427
Abstract:

Methods and compositions for preventing or treating ophthalmic diseases or disorders wherein an ophthalmically effective amount of the C. sub. 20 through C. sub. 26 aminosteroids of formula XI and their pharmaceutical, acceptable salts, hydrates or solvates is administered in an inert vehicle to arrest oxidation processes damaging to the eye.